Prescribed Stimulants For Adults Linked To Higher Incidence Of Adverse Events Compared To Placebos

Prescribed stimulants for adults are linked to a 34% higher incidence of adverse events compared to placebos, according to a meta-analysis of 93 studies describing the outcomes of clinical trials with prescription stimulants. The risk ratios for specific adverse events were consistently higher in the stimulant groups compared to the placebo groups. The adverse events included a 224% increased risk of decreased appetite, 23% for headache, 110% for insomnia, 234% for dry mouth, 101% for nausea, 15% for irritability, and 23% for anxiety. The researchers said the increasing number of stimulant prescriptions, the expanding range of therapeutic applications, and . . .